AlzeCure deploys Vortex device to develop novel therapies for Alzheimer’s disease Dotmatics' Vortex to be used to uncover new drug lead compounds for Alzheimer's disease Dotmatics, a respected service provider of scientific informatics solutions and providers to the pharmaceutical and biotechnology industries, announced today that the study foundation AlzeCure, has deployed and integrated the info analysis and visualization tool Vortex. AlzeCure is normally a novel innovative drug discovery unit that will use Vortex to help in the quest to discover and develop novel therapies for the treatment of Alzheimer's disease and other neurodegenerative disorders information more info .
And cooperation partner Teijin in Japan, the family members also contains Ciclesonide nasal spray , Ciclesonide as a set combination item with formoterol and Ciclesonide as a dry powder inhaler . Related StoriesNew therapy attacks the source of asthma, treats the disease at cellular levelSecondhand smoke exposure doubles risk of hospitalization for children with asthmaResearchers find proteins that plays crucial function in advancement of allergic airway inflammationUK served as the Reference Member Condition for the Mutual Reputation Procedure of Alvesco in other European countries. Meanwhile 20 European countries have mutually decided to the overview of product characteristics for Alvesco.